Articles On Medical Developments International (ASX:MVP)

The Australian share market may be storming higher on Thursday, but the Medical Developments International Ltd (ASX: MVP) share price hasn’t followed its lead. In morning trade the healthcare company’s shares are down 1% to $8.42. Why is t...

It is amazing how so many industries choose to hide behind their own jargon and acronyms. In IT, audio, and even the car industry – they all use terminology that makes them sound like experts in their own field but often fails to communica...

The Medical Developments International Ltd (ASX: MVP) share price is crashing lower on a day which has seen a sharp fall across most of the ASX’s major sectors.  At the time of writing, the S&P/ASX 200 Index (INDEXASX: XJO) is down 2.1...

Looking back over the past 12 months, the All Ordinaries (INDEXASX: XAO) has performed strongly, rising just over 15%. However, there are a number of shares that stood out and have managed to do even better. Below are three shares that hav...

The market may have dropped lower today, but that hasn’t stopped the Citadel Group Ltd (ASX: CGL) share price from charging higher. In afternoon trade the managed technology solutions provider’s shares are up 4% to $4.98. Why is the Citade...

Growing ASX-listed biotech company Paradigm Biopharmaceuticals Ltd (ASX: PAR) has performed strongly over the last year, with Paradigm shares skyrocketing more than 250% higher to $4.20 as at the time of writing. This means it has outperf...

The Australian market lost yesterday’s gains as the number of reported coronavirus cases nears 8000 and impacts Asian markets. Despite morning gains, the ASX 200 trailed off just over an hour into the session. The benchmark index relin...

The Opthea Ltd (ASX: OPT) share price has already surged over 20% higher in January to $3.60 as at the time of writing. Although the 52-week high of $4.15 the biotechnology company hit back in September still seems like a little way off ye...

Recently it was announced that CSL Limited (ASX: CSL) has been ranked as the third-most valuable biotech company in the world. The CSL share price cracked through the $300 per share barrier to start the year and is well poised to become th...

When looking for great long-term investments, it’s a good idea to start by looking at the big picture and asking yourself which sectors of the ASX you think will have a long-term advantage. I believe applying a macro-economic perspective t...

On Thursday the S&P/ASX 200 index broke through the 7,000 points mark for the first time in its history. But it wasn’t just the benchmark index that was hitting a new high. Several ASX shares raced to new highs of their own yesterday....

Asia is rising as a healthcare spender, matching incomes and the long-feared elderly population boom. The region is a major part of a surge in health spending that is expected over the next few years, as rising lifestyle illnesses and ages...

Outside of my portfolio holdings, I have a watchlist of around 25–30 shares I like to keep tabs on. I don’t follow them everyday, or even every week, but usually just absorb any major announcements released by the companies. Over time, thi...

The PolyNovo Ltd (ASX: PNV) share price has been a strong performer on Tuesday. The medical device company’s shares raced as much as 12% higher after returning from a trading halt this morning. They have since pulled back a touch, but are...

It’s easy to look back on ASX shares that you had wish you owned – hindsight is a marvellous thing. However, if we try to learn from it and understand what made certain companies perform better than others, maybe, just maybe, we won’t miss...

The Medical Developments International Ltd (ASX: MVP) share price has started 2020 on the right foot, up more than 5% at the time of writing and trading at all-time highs. The company’s share price outperformed in 2019, finishing the year...

Whether a day trader or a long-term investor, we often examine research released by industry experts, brokers and analysts with a view to uncovering the next big thing. The more complex the sector, the more we are likely to rely on informat...

Spies defecting, a foreign power secretly taking control of Australia via 5G, the stealthy infiltration of universities and CSIRO, a new arms race waged through cyber-warfare. This is not a John Le Carre novel, these are the headlines shapi...

Air pollution is a growing problem that in recent days has reached our own backyard. Because of the bushfires in surrounding areas, Sydney’s air has been ranked the ninth worst in the world. It’s not the first time in history it’s happened...

The S&P/ASX 200 index has followed the lead of U.S. markets and is pushing higher on Monday. In afternoon trade the benchmark index is up 0.4% to 6,733.8 points. Four shares that are climbing more than most today are listed below. Here...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Friday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.36% to...

The Medical Developments International Ltd (ASX: MVP) share price is pushing higher on Friday. In late morning trade the healthcare company’s shares are up 1% to $7.16. Why is the Medical Developments International share price pushing high...

New Zealand’s medicines regulator has recommended the country fall in line with Australia’s new codeine restrictions, and pharmaceutical companies are backing the decision. Yesterday, Medsafe recommended that all medications containing code...

It has been a very disappointing day of trade for the S&P/ASX 200 index on Tuesday. In afternoon trade the benchmark index is down a sizeable 1.95% to 6,728.6 points. Four shares that have defied the market sell off today are listed be...

On 2 December 2019, the S&P/ASX 200 Health Care Sector (XHJ) traded higher at 42,106.3 points, with a rise of 0.83% compared to the last close. The S&P/ASX 200 Index traded at 6,862.3 points, up by 0.24% from its previous close. YT...

The uncertainties in almost every aspect of human life are uninvited guests for which not everyone is prepared. Similarly, many investors put their hard-earned money into risk carrying investment vehicles without having the knowledge of the...

Medical Developments International (ASX:MVP) has announced that the Chinese National Medical Product Administration (NMPA) has approved the opening of its Investigative New Drug (IND) application for Penthrox.

Although it gave back some of its morning gains, the S&P/ASX 200 index was on form again on Monday. The benchmark index finished the day 0.3% higher at 6,731.4 points. This led to a good number of shares charging higher, with some even...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Thursday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.79% to...

In afternoon trade the S&P/ASX 200 index is having another day to forget. At the time of writing the benchmark index is down a sizeable 1% to 6,655.9 points. Four shares that have not let that hold them back today are listed below. Her...

The Titomic Ltd (ASX: TTT) share price has been amongst the best performers on the market on Thursday. In morning trade the digital manufacturing solutions company’s shares are up 14% to $1.28. Why is the Titomic share price rocketing high...

The Medical Developments International (ASX: MVP) share price is up 8% after making an announcement to investors. Medical Developments International is a healthcare company focused on emergency pain relief and respiratory products. The comp...

The Medical Developments International Ltd (ASX: MVP) share price has been a strong performer on Thursday morning. At the time of writing the healthcare company’s shares are up 5% to $6.33. Why is the Medical Developments International sha...

The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price was on form again on Thursday. The biopharmaceutical company’s shares pushed 4% higher to $2.93 on the day of its annual general meeting. This latest gain means the Paradigm share...

The Medical Developments International Ltd  (ASX: MVP) share price was one of the big gainers on the ASX last month. The Aussie medical devices group had a huge month amid announcing a new CSIRO deal and several strong Penthrox updates. Wh...

The Medical Developments International Ltd (ASX: MVP) share price will be on watch on Tuesday following the release of a positive announcement. What did Medical Developments International announce? This morning Medical Developments Interna...

Australia has an excellent medical research, and health care infrastructure, as a result the Australian health care system has been the global benchmark for decades. In Australia, the health care industry is backed by the national and state...

Melbourne-based Medical Developments International (ASX:MVP) has announced that Penthrox, its fast-onset, non-opioid analgesic for pain relief by self-administration, has been launched in Italy.

23 Oct 2019 - Medical Developments International (ASX:MVP) is delighted to announce that Penthrox has been launched in Italy.

Botanix Pharmaceuticals’ (ASX:BOT) shares have halved after its anti-acne drug failed its clinical trial. If you read most of the company’s announcement and you’d would have thought the 368 patient trial was a success. Its drug, BTX 1303, w...

It has been a positive day of trade for the S&P/ASX 200 index on Tuesday. At the time of writing the benchmark index is up 0.25% to 6,670.4 points. Four shares that are climbing more than most today are listed below. Here’s why they ar...

The Cochlear Limited (ASX: COH) share price has dropped lower on Tuesday following the release of its AGM update. In morning trade the hearing solutions company’s shares are down 3% to $207.89. What was in Cochlear’s update? Much of today’...

In morning trade the Megaport Ltd (ASX: MP1) share price has sunk lower despite the release of a solid first quarter update. At the time of writing the shares of the leading provider of elastic interconnection services are down 8% to $9.43...

The Medical Developments International Ltd (ASX: MVP) share price will be on watch this morning follow a positive announcement relating to its Penthrox product. What is Penthrox? Penthrox, or the green whistle, is a fast onset, non-opioid...

ResMed Inc (ASX: RMD) has grown exponentially over the last few years, and is now a large-cap company and one of the leading healthcare blue-chips trading on the ASX, alongside the likes of CSL Limited (ASX: CSL) and Cochlear Limited (AS...

You may have heard about an opioid crisis over in the US; it was declared a public health emergency in 2017 amid 130 deaths every day from opioid-related drug overdoses and 2.1 million people with an opioid use disorder. In Australia, the p...

The notion of ‘everything old is new again’ applies not just to fickle fashion trends, but to drug development as well. Drug reformulations are all the rage and it’s not such a bad thing. Think of Paradigm Biopharmaceuticals (ASX:PAR) with...

The Medical Developments International Ltd (ASX: MVP) share price is on the rise today after the company reported its results for the 2019 financial year (FY19) this morning. MVP shares opened at $4.76, but have since jumped to $4.94 at th...

The Australian health system is tagged amongst the best in the world and focusses on providing safe and affordable health care for all the Australians. The federal, state and local government jointly run the system to ensure its adherence....

Healthcare being a large industry in Australia is a significant contributor to the country’s economy. The below-mentioned ASX listed healthcare stocks have been performing well over the past few months, plus have made strong operational pro...